Harshini Chinnasamy

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas

Robbie G. Majzner, Sneha Ramakrishna, Kristen W. Yeom et al. · Nature · 2022 · 782 citations · Full text

Medicine, Immunology, Oncology +13

Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer

Nikolaos Zacharakis, Harshini Chinnasamy, Mary A. Black et al. · Nature Medicine · 2018 · 778 citations

Medicine, Immunology, Oncology +17

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Jay Y. Spiegel, Shabnum Patel, Lori Muffly et al. · Nature Medicine · 2021 · 572 citations · Full text

Medicine, Hematology, Oncology +17

Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas

Michelle Monje, Jasia Mahdi, Robbie G. Majzner et al. · Nature · 2024 · 173 citations · Full text

Medicine, Oncology, Pharmacology +15

CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

Matthew J. Frank, John H. Baird, Anne Marijn Kramer et al. · The Lancet · 2024 · 57 citations · Full text

Medicine, Hematology, Oncology +16